Treatment selection for patients with relapsed or refractory follicular lymphoma

Overview of attention for article published in Frontiers in oncology, March 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 6 X posts from 4 X users, with an upper bound of 10,020 followers.

RT @Lymphoma_Papers: Treatment selection for patients with relapsed or refractory follicular lymphoma #lymphoma #lymsm https://t.co/u2uA5Hw…

RT @Lymphoma_Papers: Treatment selection for patients with relapsed or refractory follicular lymphoma #lymphoma #lymsm https://t.co/u2uA5Hw…

Treatment selection for patients with relapsed or refractory follicular lymphoma #lymphoma #lymsm https://t.co/yru31Liy1e

Treatment selection for patients with relapsed or refractory follicular lymphoma #lymphoma #lymsm https://t.co/u2uA5HwZ2c

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.